Literature DB >> 20387901

Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin.

Matthew W Parker1, Lance M Hellman, Ping Xu, Michael G Fried, Craig W Vander Kooi.   

Abstract

Neuropilin is an essential cell surface receptor that functions in both semaphorin-dependent axon guidance and vascular endothelial growth factor (VEGF)-dependent angiogenesis. The interplay between these two seemingly distinct pathways is a source of considerable interest. Indeed, several semaphorin family members have been shown to have potent anti-angiogenic activity in vivo. However, reports about whether semaphorin and VEGF competitively bind to neuropilin conflict. Previous work has demonstrated that all known ligands and inhibitors of neuropilin interact with the b1 domain of neuropilin via a C-terminal arginine. No semaphorin family member possesses a C-terminal arginine, leading to uncertainty with regard to the physical mechanism of interaction between the C-terminal domain of semaphorin and the b1 domain of neuropilin. Semaphorin 3F (Sema3F) possesses an RXRR furin recognition site in its C-terminus, and we demonstrate that it is proteolytically processed. This processing is found to be essential for the interaction of the C-terminus of Sema3F with the b1 domain of neuropilin. We further demonstrate that furin activation of the C-terminus of Sema3F produces a species that potently inhibits the binding of VEGF to neuropilin. These studies provide a mechanistic basis for understanding the anti-angiogenic activity of semaphorin as well as the physical interaction and competition between neuropilin ligands.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387901      PMCID: PMC2868107          DOI: 10.1021/bi100327r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems.

Authors:  Peter Schuck; Matthew A Perugini; Noreen R Gonzales; Geoffrey J Howlett; Dieter Schubert
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

Review 2.  Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development.

Authors:  Hajime Fujisawa
Journal:  J Neurobiol       Date:  2004-04

3.  Processing of the HTLV-II envelope precursor glycoprotein gp63 by furin is essential for cell fusion activity.

Authors:  Hideki Hasegawa; Masashi Tatsumi; Kiyoko Ogawa-Goto; Hidehiro Takahashi; Asato Kojima; Takuya Iwasaki; Takeshi Kurata; Tetsutaro Sata; Toshiyuji Takeuchi; Noreen Sheehy; Hirofumi Sawa; Kazuo Nagashima; William W Hall
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-20       Impact factor: 2.205

4.  Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.

Authors:  Chenghua Gu; Brian J Limberg; G Brian Whitaker; Ben Perman; Daniel J Leahy; Jan S Rosenbaum; David D Ginty; Alex L Kolodkin
Journal:  J Biol Chem       Date:  2002-03-08       Impact factor: 5.157

5.  Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.

Authors:  Roni Mamluk; Ze'ev Gechtman; Matthew E Kutcher; Nijole Gasiunas; John Gallagher; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

6.  The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.

Authors:  G Fuh; K C Garcia; A M de Vos
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

Review 7.  The role of neuropilin in vascular and tumor biology.

Authors:  Michael Klagsbrun; Seiji Takashima; Roni Mamluk
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

8.  Semaphorin 3F is critical for development of limbic system circuitry and is required in neurons for selective CNS axon guidance events.

Authors:  Amar Sahay; Mark E Molliver; David D Ginty; Alex L Kolodkin
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

9.  Semaphorin-3F is an inhibitor of tumor angiogenesis.

Authors:  Ofra Kessler; Niva Shraga-Heled; Tali Lange; Noga Gutmann-Raviv; Edmond Sabo; Limor Baruch; Marcelle Machluf; Gera Neufeld
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

10.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.

Authors:  Tambet Teesalu; Kazuki N Sugahara; Venkata Ramana Kotamraju; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

View more
  35 in total

Review 1.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

3.  Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.

Authors:  Matthew W Parker; Ping Xu; Xiaobo Li; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 4.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

5.  P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer.

Authors:  Hira Lal Goel; Bryan Pursell; Leonard D Shultz; Dale L Greiner; Rolf A Brekken; Craig W Vander Kooi; Arthur M Mercurio
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

6.  Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.

Authors:  Matthew W Parker; Andrew D Linkugel; Hira Lal Goel; Tingting Wu; Arthur M Mercurio; Craig W Vander Kooi
Journal:  Structure       Date:  2015-03-05       Impact factor: 5.006

7.  Mixed dimers of insulin-degrading enzyme reveal a cis activation mechanism.

Authors:  Eun Suk Song; David W Rodgers; Louis B Hersh
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

8.  Microplate-based screening for small molecule inhibitors of neuropilin-2/vascular endothelial growth factor-C interactions.

Authors:  Matthew W Parker; Craig W Vander Kooi
Journal:  Anal Biochem       Date:  2014-02-26       Impact factor: 3.365

Review 9.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

10.  Inhibition of Semaphorin3A Promotes Ocular Dominance Plasticity in the Adult Rat Visual Cortex.

Authors:  Elena Maria Boggio; Erich M Ehlert; Leonardo Lupori; Elizabeth B Moloney; Fred De Winter; Craig W Vander Kooi; Laura Baroncelli; Vasilis Mecollari; Bas Blits; James W Fawcett; Joost Verhaagen; Tommaso Pizzorusso
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.